The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial
2014 ◽
Vol 28
(3)
◽
pp. 323-327
◽
2011 ◽
Vol 92
(2)
◽
pp. 253-260
◽
2008 ◽
Vol 102
(4)
◽
pp. 434-439
◽
2012 ◽
Vol 34
(9)
◽
pp. 1909-1919.e15
◽
Keyword(s):
Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
2007 ◽
Vol 3
(1)
◽
pp. 33-39
◽
2018 ◽
Vol 143
◽
pp. 204-214
◽
2019 ◽
Vol 38
(8)
◽
pp. 714-721
◽